Shopping Ads vs. Free Listings for Peptide Stores: Eligibility, Risk and What Actually Differs

What is the difference between Shopping ads and free listings for a peptide store?

Shopping ads and free listings both come from the same Merchant Center product data and, since September 2026, are governed by one consolidated set of Google Shopping policies. Shopping ads are paid placements that also need a linked Google Ads account in good standing; free listings cost nothing and need only Merchant Center. For peptide stores, the restrictions that matter most — healthcare and medicines, unapproved pharmaceuticals and supplements, misrepresentation — apply to both, so free listings are not a way around a disapproval.

That last point is where most confusion starts. Founders often assume that because free listings are “organic,” they sit outside ad policy. They do not. Google’s own healthcare policy for Shopping says the restrictions vary by product and country, and that “some content, such as unapproved pharmaceutical supplements, may not be listed anywhere.”

If you already know your store has item or account issues, start with product disapproval vs. account suspension first. This page assumes you are deciding how to use the two surfaces, not recovering from a suspension.

How do Shopping ads and free listings compare side by side?

Question	Free listings	Shopping ads
Cost	No cost per click	Paid per click through Google Ads
Accounts needed	Merchant Center only	Merchant Center plus a linked Google Ads account
Policies	Google Shopping ads and listings policies	The same policies, plus rules marked “Shopping ads only” and Google Ads policies for the account
Healthcare and unapproved substances	Apply	Apply
Where products can appear	Google lists Search, Maps, Gemini, YouTube, the Shopping tab, Images and Lens	Ad slots on Search, the Shopping tab and other Google surfaces, depending on campaign type
Default status	New Merchant Center accounts are opted in by default	Nothing serves until a campaign is built and funded
Control	Product data only; no bids, no negative keywords	Bids, budgets, negative keywords, product grouping, schedules
Extra exposure	Merchant Center account standing	Merchant Center standing and Google Ads account standing, verification and billing

The comparison that matters for peptide operators is the last row. Every paid surface you add is another account that can be warned, restricted or suspended. That is not a reason to avoid Shopping ads; it is a reason to switch them on only when the base is stable.

Can a peptide store still show in free listings if its Shopping ads are disapproved?

It depends on why the ads are not serving. There are three distinct situations, and they have different answers.

Situation	Free listings affected?	Why
Product disapproved under a shared Shopping policy (healthcare, unapproved substances, misrepresentation)	Yes	The same policy governs both surfaces since consolidation
A rule marked “Shopping ads only,” or a campaign-side problem (budget, billing, bid strategy)	Usually not	The restriction or problem sits on the paid side only
The linked Google Ads account is suspended	Potentially yes	Merchant Center has a “Linked account suspension” reason: a suspended Google Ads account linked to Merchant Center must be fixed first, and Google says unlinking does not resolve it

The third row is the one that catches peptide stores out. An operator opens a Google Ads account, runs a keyword-led Search campaign on drug-name terms, the Ads account is suspended — and a Merchant Center account that was quietly earning free listings gets pulled into it. Our account recovery guide covers the sequence for fixing linked suspensions.

Which peptide products are most exposed on either surface?

Google’s healthcare and medicines policy for Shopping restricts four groups: over-the-counter medication, prescription drugs, unapproved pharmaceuticals and supplements, and pregnancy and fertility products. For peptide catalogues, the first two questions are almost always prescription status and the unapproved list.

• Prescription drugs. In the United States and Canada, Google allows some prescription drugs only from online pharmacies accredited by LegitScript or by NABP (VIPPS or Pharmacy Verified Websites) that then apply for Google certification. Everywhere else, prescription listings are not allowed. GLP-1 molecules such as semaglutide and tirzepatide are prescription drugs; listing them without that certification is a disapproval, not a grey area. See our LegitScript certification guide.
• Unapproved pharmaceuticals and supplements. Google publishes an example list and says the policy also covers “substances with similar chemical composition” and “products with names that are confusingly similar” to listed items. The list we read on 27 September 2026 is dominated by branded supplements, ephedra and steroid products and several hCG diet products. It does not name common research peptides — but it is non-exhaustive, so absence from the list is not approval.
• Products under regulatory action. Google’s Unapproved Substances policy for ads bans products subject to government or regulatory action. On 24 August 2026 FDA sent a wave of warning letters to online peptide sellers naming products including semaglutide, tirzepatide, retatrutide, PT-141 and tesamorelin as unapproved new drugs. Our Unapproved Substances guide explains how that interacts with Google review.

The practical consequence: a peptide store usually cannot make a catalogue-wide decision. Some items may list; others will be disapproved on either surface; a few may create account-level risk if they stay on the website at all. excluded_destination can keep an item out of one surface, but it does not change what Google sees on your site.

What does a peptide store need for free listings to work?

Free listings have fewer moving parts than Shopping ads, but they are not automatic. From Google’s free listings documentation:

1. Opt-in. New Merchant Center accounts are opted in by default. Existing accounts can check the Free listings card under Marketing → Marketing methods. Stores syncing through the Google & YouTube app on Shopify are opted in automatically.
2. Required attributes. ID, title, link, image link, price, description and availability are the foundation, with more required for some categories and countries.
3. Shipping. Shipping settings or a shipping attribute are required in the United States, the United Kingdom, Canada, Australia and most of Europe, among other countries.
4. Returns. Google recommends adding a return policy in Merchant Center; it can appear next to your products.
5. Product pages only. Free listings point to product pages, not homepages, category pages or policy pages.
6. Policy compliance. The same Shopping ads and listings policies as paid ads, including site requirements.

One detail peptide operators should know: Google says it may still show products crawled from your online store even if free listings are turned off, unless you use crawl and indexing controls. Turning the switch off in Merchant Center is not the same as removing a product from Google’s view. If a product should not be sold, it should not be on the site.

Should a peptide store start with free listings before paying for Shopping ads?

For most peptide stores we would sequence it that way, for a reason that has nothing to do with cost: free listings give you a low-stakes read on how Google classifies your catalogue before you add a second account to the risk.

1. Upload and wait for review. Google says initial product review commonly takes 3–5 business days, and approved items can go live within about 24 hours.
2. Read item statuses by issue, not by count. Healthcare or unapproved-substance disapprovals tell you which products will also fail as ads. Data issues (price mismatch, missing shipping) are fixable and do not predict policy outcomes.
3. Watch for account-level warnings. A healthcare warning comes with a 7- or 28-day window and one courtesy review. Misrepresentation can suspend on detection. Either one is a signal to fix the site before any paid spend.
4. Only then connect Google Ads. Complete advertiser verification, set up billing, and build Shopping or Performance Max campaigns from items that have been stable.

We do not claim free listings will drive meaningful sales for a peptide store; visibility depends on your data, your category and demand, and Google says listings are not guaranteed to show. The value is diagnostic. Our Shopping feed and campaign structure guide covers what to build once you are ready for paid campaigns.

What should you check before switching on Shopping ads?

• No account-level warnings or suspensions in Merchant Center, and no unresolved healthcare issues.
• Every item you plan to advertise has been approved and stable for at least one full review cycle.
• Products that cannot be presented compliantly are removed from the website, not just excluded from the feed.
• Prescription products are either certified (LegitScript or NABP, then Google) or absent.
• Price, availability and shipping on the site match the feed; structured data is present on product pages.
• The Google Ads account is verified, billed and not running keyword campaigns on prescription drug names.
• You understand that the Ads account and Merchant Center will be linked, and that an Ads suspension can reach Merchant Center.

If you want a structured view of where your store stands before connecting paid campaigns, the Google Ads Readiness Score takes about five minutes. For a review of your specific catalogue, book a strategy call.

Sources

• Google Merchant Center Help — Google’s Shopping ads and listings policies (the former free listings policies URL resolves to the same page)
• Google Merchant Center Help — Merchant Center announcements change log (September 2026 policy consolidation)
• Google Merchant Center Help — Healthcare and medicines and Unapproved pharmaceuticals and supplements
• Google Merchant Center Help — Free listings for products and Show your products for free on Google (Shopify)
• Google Merchant Center Help — Linked account suspension
• U.S. FDA — Warning letter 734884 (24 August 2026), one of the August 2026 peptide warning letters

Checked 2026-09-27. Google policies change; the live help centre governs.

Frequently asked